A comprehensive view of Pfizer Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.
Australia: Pfizer, The Regents of the University of California Receive Patent for 'LFA3 variants and compositions and uses thereof'
Published:
May 10, 2024
by Australian Government
|
Pfizer reportedly agrees to settle over 10,000 Zantac-related cases reports Bloomberg; lawsuits allege Pfizer did not disclose the cancer risks of the heartburn medication
Published:
May 09, 2024
by Punch, The (Nigeria)
|
Pfizer Seeks Patent for Compound for the Treatment of Cancer
Published:
May 09, 2024
by Medical Patent News
|
PFIZER INC - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
May 08, 2024
by SEC Edgar Filings
|
Hong Kong and Macau approve Pfizer’s bivalent, single-dose vaccine that targets RSV A and RSV B in older adults and infants; vaccine to be available in Macau in June 2024 and Hong Kong by August 2024
Published:
May 08, 2024
by Macau Business
|
Ask us about our Logistic & Supply Chain market view